Goodwin: Delphia Therapeutics Completes $67M Series A
May 07, 2024
May 07, 2024
BOSTON, Massachusetts, May 7 -- Goodwin, a law firm, issued the following news release:
The Life Sciences and Technology teams advised Delphia Therapeutics on the closing of its $67 million Series A financing led by premier early life sciences investors including GV (Google Ventures), Nextech Invest, Polaris Innovation Fund and Alexandria Venture Investments.
Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeuti . . .
The Life Sciences and Technology teams advised Delphia Therapeutics on the closing of its $67 million Series A financing led by premier early life sciences investors including GV (Google Ventures), Nextech Invest, Polaris Innovation Fund and Alexandria Venture Investments.
Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeuti . . .